HUT65702A - 1,2-dithiole-3-thione-derivative-based therapeutical compositions - Google Patents

1,2-dithiole-3-thione-derivative-based therapeutical compositions

Info

Publication number
HUT65702A
HUT65702A HU9303113A HU9303113A HUT65702A HU T65702 A HUT65702 A HU T65702A HU 9303113 A HU9303113 A HU 9303113A HU 9303113 A HU9303113 A HU 9303113A HU T65702 A HUT65702 A HU T65702A
Authority
HU
Hungary
Prior art keywords
dithiole
thione
derivative
therapeutical compositions
based therapeutical
Prior art date
Application number
HU9303113A
Other languages
English (en)
Other versions
HU225498B1 (en
HU9303113D0 (en
Inventor
Marie-Odile Christen
Jean-Louis Burgot
Original Assignee
Therapeutique Moderne Lab De
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Therapeutique Moderne Lab De filed Critical Therapeutique Moderne Lab De
Publication of HU9303113D0 publication Critical patent/HU9303113D0/hu
Publication of HUT65702A publication Critical patent/HUT65702A/hu
Publication of HU225498B1 publication Critical patent/HU225498B1/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D515/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D515/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D515/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/02—Five-membered rings
    • C07D339/04—Five-membered rings having the hetero atoms in positions 1 and 2, e.g. lipoic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pulmonology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HU9303113A 1991-05-02 1992-04-30 1,2-dithiole-3-thione-derivatives therapeutical compositions containing them, and process for production of the active agent and the composition HU225498B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9105411A FR2676057B1 (fr) 1991-05-02 1991-05-02 Derives de 1,2-dithiole-3-thione, procede de preparation de ces derives, ainsi que l'utilisation de ces derives comme intermediaires de synthese ou comme medicaments.
PCT/FR1992/000392 WO1992019613A2 (fr) 1991-05-02 1992-04-30 Compositions therapeutiques a base de derives de 1,2-dithiole-3-thione

Publications (3)

Publication Number Publication Date
HU9303113D0 HU9303113D0 (en) 1994-01-28
HUT65702A true HUT65702A (en) 1994-07-28
HU225498B1 HU225498B1 (en) 2007-01-29

Family

ID=9412462

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9303113A HU225498B1 (en) 1991-05-02 1992-04-30 1,2-dithiole-3-thione-derivatives therapeutical compositions containing them, and process for production of the active agent and the composition

Country Status (11)

Country Link
US (2) US5470871A (hu)
EP (1) EP0576619B1 (hu)
JP (1) JP3226920B2 (hu)
AU (1) AU1768592A (hu)
DE (1) DE69201302T2 (hu)
DZ (1) DZ1576A1 (hu)
ES (1) ES2070002T3 (hu)
FR (1) FR2676057B1 (hu)
HU (1) HU225498B1 (hu)
WO (1) WO1992019613A2 (hu)
ZA (1) ZA923169B (hu)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69734734D1 (de) * 1996-07-05 2005-12-29 Us Gov Health & Human Serv Gesättigte 1,2-dithiaheterocyclische verbindungen enthaltende antivirale pharmazeutische zubereitungen
US6185810B1 (en) 1997-06-18 2001-02-13 The United States Of America As Represented By The Secretary Of The Navy Method of making high temperature superconducting ceramic oxide composite with reticulated metal foam
WO2002026909A1 (en) * 2000-09-29 2002-04-04 Trustees Of Dartmouth College Compositions and methods for thionation during chemical synthesis reactions
US7012148B2 (en) * 2001-09-25 2006-03-14 Trustees Of Dartmouth College Compositions and methods for thionation during chemical synthesis reactions
KR100484526B1 (ko) * 2002-11-13 2005-04-20 씨제이 주식회사 티온 유도체, 그 제조방법 및 약제학적 조성물
AU2003284759A1 (en) * 2003-11-25 2005-06-17 Cj Corporation Thione derivatives, processes for the preparation thereof, and pharmaceutical compositions containing the same
KR100604261B1 (ko) * 2004-10-11 2006-07-28 재단법인서울대학교산학협력재단 신규4,5,6,7-테트라히드로-[1,2]디티올로[4,3-ｃ]피리딘-3-티온계 화합물
US20070299093A1 (en) * 2005-01-27 2007-12-27 Alma Mater Studiorum-Universitá Di Bologna Organic Compounds Useful for the Treatment of Alzheimer's Disease, Their Use and Method of Preparation
EA200701584A1 (ru) * 2005-01-27 2008-02-28 Альма Матер Студиорум - Университа' Ди Болонья Органические соединения, применяемые для лечения болезни альцгеймера, их применение и способ получения
US8464813B2 (en) * 2006-06-20 2013-06-18 Atlas Copco Secoroc Llc Cutter assembly for a raise boring reamer
CN101429190B (zh) * 2007-08-24 2013-03-27 沈阳药科大学 4,5-二取代苯基-3h-1,2-二硫杂环戊烯-3-硫酮、-酮、-酮肟类衍生物及其用途
AR075713A1 (es) * 2009-03-03 2011-04-20 Du Pont Pirazoles fungicidas
RU2534525C9 (ru) * 2013-09-24 2015-02-10 Федеральное государственное бюджетное учреждение науки Тихоокеанский институт биоорганической химии им. Г.Б. Елякова Дальневосточного отделения Российской академии наук (ТИБОХ ДВО РАН) Гликозидные производные 1,2-дитиол-3-тиона или 1,2-дитиол-3-она и лекарственные средства на их основе

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE909097C (de) * 1951-02-28 1954-04-12 Wander Ag Dr A Verfahren zur Herstellung von Trithionen
US4190727A (en) * 1971-06-25 1980-02-26 Petrolite Corporation Dithioles

Also Published As

Publication number Publication date
DE69201302D1 (de) 1995-03-09
WO1992019613A2 (fr) 1992-11-12
FR2676057A1 (fr) 1992-11-06
HU225498B1 (en) 2007-01-29
DE69201302T2 (de) 1995-09-28
JPH06506936A (ja) 1994-08-04
US5470871A (en) 1995-11-28
EP0576619B1 (fr) 1995-01-25
JP3226920B2 (ja) 2001-11-12
AU1768592A (en) 1992-12-21
FR2676057B1 (fr) 1995-03-03
DZ1576A1 (fr) 2002-02-17
EP0576619A1 (fr) 1994-01-05
WO1992019613A3 (fr) 1993-02-18
ZA923169B (en) 1993-11-01
HU9303113D0 (en) 1994-01-28
US5750560A (en) 1998-05-12
ES2070002T3 (es) 1995-05-16

Similar Documents

Publication Publication Date Title
HU9202848D0 (en) 1,2-dihydro-2-oxopyridine
SG43866A1 (en) Hyperglycemic compositions
GB9102579D0 (en) Compositions
EP0569493A4 (en) Substituted 4,6-di-tertiary-butyl-5-hydroxy-pyrimidines
ZA929508B (en) Insecticidal compositions
HK19496A (en) Use of 1,2,2,3,3-penta-fluoropropane
ZA92342B (en) Lice-repellant compositions
GB2260135B (en) Substituted 2,6-diaminotoluenes
HUT65702A (en) 1,2-dithiole-3-thione-derivative-based therapeutical compositions
GB9114099D0 (en) Compositions
GB9101592D0 (en) Compositions
ZA924657B (en) Pesticidal compositions
GB9101655D0 (en) Compositions
GB9121219D0 (en) New compositions
GB9101654D0 (en) Compositions
CS32591A3 (en) 1,2,3,4-di-0-isopropyliden-6-0-epoxypropyl-alpha-d-galactopyranose
GB2266530B (en) Substituted 1,1,2-triphenylbutenes
GB9109973D0 (en) Therapeutic compositions
GB9123044D0 (en) Compositions
GB9116920D0 (en) Compositions
GB9123026D0 (en) Compositions
GB9119673D0 (en) Compositions
GB9117418D0 (en) Compositions
GB9117211D0 (en) Compositions
GB9116923D0 (en) Compositions

Legal Events

Date Code Title Description
MM4A Lapse of definitive patent protection due to non-payment of fees